US fines Teva Glenmark 255 mn over drug pricefixing charges Weekly Voice

Washington, Aug 22 (VOICE) The US has fined top drug-making companies Teva Pharmaceuticals and Glenmark Pharmaceuticals a total of $255 million for price-fixing fixing medications, including a generic cholesterol drug that they will now divest. The Department of Justice (DoJ) announced that Teva will also make a $50 million drug…Read More